该发明涉及式(I)的磺胺基衍生物,
其中
R
C
是可选取代的含有一个或多个N原子的4-6元杂环环,或
R
C
与其连接的苯环一起形成苯二氧杂基团,或
R
C
是-NR
1
R
2
,
R
A
是具有式的基团
R
B
是氢或烷基。
该发明还涉及将式(I)的衍生物用作胶原受体整合素的抑制剂以及制备式(I)的磺胺基的方法。
The invention relates to sulphonamide derivatives of formula (I),
where
R
C
is optionally substituted 4-6-membered heterocyclic ring containing one or more N atoms, or
R
C
forms together with the phenyl ring to which it is attached a benzodioxolyl group, or
R
C
is —NR
1
R
2
,
R
A
is a group having the formula
R
B
is hydrogen or alkyl.
The invention also relates to the use of derivatives of formula (I) as inhibitors for collagen receptor integrins and a process for preparing sulphonamides of formula (I).
该发明涉及式(I)的磺胺基衍生物,
其中
R
C
是可选取代的含有一个或多个N原子的4-6元杂环环,或
R
C
与其连接的苯环一起形成苯二氧杂基团,或
R
C
是-NR
1
R
2
,
R
A
是具有式的基团
R
B
是氢或烷基。
该发明还涉及将式(I)的衍生物用作胶原受体整合素的抑制剂以及制备式(I)的磺胺基的方法。
[EN] IMIDAZOPYRIDINE-DERIVATIVES AS INDUCIBLE NO-SYNTHASE INHIBITORS<br/>[FR] DERIVES IMIDAZOPYRIDINE SERVANT D'INHIBITEURS DE NO-SYNTHASE INDUCTIBLE
申请人:ALTANA PHARMA AG
公开号:WO2005030770A1
公开(公告)日:2005-04-07
The compounds of formula (I) in which R1, R2, R3, R4, R5 and A have the meanings as given in the description are novel effective iNOS inhibitors.